Reviva Net Income Applicable To Common Shares from 2010 to 2024
| RVPH Stock | USD 1.49 0.04 2.76% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -21.9 M | Current Value -20.8 M | Quarterly Volatility 8.5 M |
Check Reviva Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Reviva Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Expense of 156.3 K, Income Tax Expense of 25.1 K or Tax Provision of 10 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 6.36. Reviva financial statements analysis is a perfect complement when working with Reviva Pharmaceuticals Valuation or Volatility modules.
Reviva | Net Income Applicable To Common Shares |
Latest Reviva Pharmaceuticals' Net Income Applicable To Common Shares Growth Pattern
Below is the plot of the Net Income Applicable To Common Shares of Reviva Pharmaceuticals Holdings over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Reviva Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Reviva Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
Net Income Applicable To Common Shares |
| Timeline |
Reviva Net Income Applicable To Common Shares Regression Statistics
| Arithmetic Mean | (6,355,336) | |
| Coefficient Of Variation | (133.81) | |
| Mean Deviation | 6,687,371 | |
| Median | (1,680,355) | |
| Standard Deviation | 8,504,274 | |
| Sample Variance | 72.3T | |
| Range | 23.5M | |
| R-Value | (0.75) | |
| Mean Square Error | 33.8T | |
| R-Squared | 0.57 | |
| Significance | 0 | |
| Slope | (1,430,575) | |
| Total Sum of Squares | 1012.5T |
Reviva Net Income Applicable To Common Shares History
About Reviva Pharmaceuticals Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Reviva Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Reviva Pharmaceuticals investors use historical funamental indicators, such as Reviva Pharmaceuticals's Net Income Applicable To Common Shares, to determine how well the company is positioned to perform in the future. Although Reviva Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Reviva Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Reviva Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Reviva Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Reviva Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -21.9 M | -20.8 M |
Currently Active Assets on Macroaxis
| CART | Maplebear Common Stock | |
| OPK | Opko Health | |
| AVAI | Avant Technologies | |
| VEOEY | Veolia Environnement SA | |
| GOOG | Alphabet Inc Class C |
Additional Information and Resources on Investing in Reviva Stock
When determining whether Reviva Pharmaceuticals is a strong investment it is important to analyze Reviva Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Reviva Pharmaceuticals' future performance. For an informed investment choice regarding Reviva Stock, refer to the following important reports:Check out the analysis of Reviva Pharmaceuticals Correlation against competitors. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Reviva Pharmaceuticals. If investors know Reviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Reviva Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.59) | Return On Assets (1.92) | Return On Equity (17.95) |
The market value of Reviva Pharmaceuticals is measured differently than its book value, which is the value of Reviva that is recorded on the company's balance sheet. Investors also form their own opinion of Reviva Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Reviva Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Reviva Pharmaceuticals' market value can be influenced by many factors that don't directly affect Reviva Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Reviva Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Reviva Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Reviva Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.